RESUMO

Germ cell transplantation in fish is a promising technique for surrogate broodstock parents with broader application in aquaculture and conserving endangered and valuable genetic resources. Herein, we describe the establishment of an intrapapillary xenogeneic transplant of germ cells from sexually mature goldfish (C. auratus) males into common carp (C. carpio) males cytoablated with a thermochemical treatment (two doses of busulfan at 40 mg/kg at 35°C). To analyze the presence and development of donor germ cells in recipient testes, donor germ cells were labeled with PKH26, a fluorescent cell membrane dye, before transplantation. Our results demonstrated that thermochemical treatment caused effective spermatogenesis suppression and pronounced germ cell loss. Moreover, transplanted spermatogonial cells were able to colonize the recipients' testes, resume spermatogenesis, and generate spermatozoa within eight weeks after germ cell transplantation. These findings suggested that recipient testes provided suitable conditions for the survival, colonization, proliferation, and differentiation of donor spermatogonia from a related species. This study indicated that recipients' testes exhibited a high degree of plasticity to accept and support xenogeneic donor germ cells, which were able to form sperm in a short time frame. This approach has significant implications for assisted animal reproduction, biotechnology, conservation, and the production of valuable genetic resources and endangered fish species.

RESUMO

This study aimed to evaluate the clinical safety of doxycycline treatment (Sandoz Pharmacetical Industry from Brazil Ltd.), administered orally incorporated into the feed of Nile tilapia, Oreochromis niloticus. For this purpose, 75 Nile tilapia (±300g) from the same spawning were randomly distributed in 15 tanks (n=5), containing 100 L of water each, supplied with running water free from chlorine, to establish the following treatments: TO (Control - not treated with doxycycline); T1, T2, T3 and T4 (treated with 10, 20, 40 and 80mg of doxycycline/kg of body weight, respectively), in which 5 animals per treatment were sampled in 3 periods: 2, 4 and 8 days post-treatment (DPT). Blood samples were collected for hemogram determination and serum biochemical evaluation, as well as spleen, liver and kidneys (cranial and caudal) for somatic and histopathological evaluation. The results showed no significant difference among treatments in the serum values of creatinine, total protein, cholesterol, triglycerides, globulin, glycemia and alkaline phosphatase enzyme activity. However, serum levels of AST (aspartate aminotransferase) were significantly higher (P<0.05) in animals treated with 80 mg of doxycycline in the longest period of treatment (8 days). In the hematological evaluation of tilapia treated with doxycycline, no significant changes (P>0.05) were observed in erythrocyte counts, hematocrit, MCV, HCM and CHCM values. Doxycycline-treated tilapia did not present significant difference in the somatic analysis of spleen, liver and kidney when compared to control group. Therefore, the results demonstrated the clinical safety of oral treatment with doxycycline at doses of 10, 20, 40 and 80 mg/kg of b.w., although transient changes in liver functionality were observed after eight days of treatment with the dose of 80mg/kg.

Este estudo teve por objetivo avaliar a segurança clínica do tratamento com doxiciclina (Sandoz do Brasil Indústria Farmacêutica Ltda.), administrada via oral incorporada à ração em tilápias do Nilo, Oreochromis niloticus. Para tal, foram utilizadas 75 tilápias no Nilo (±300g) oriundas da mesma desova foram distribuídas aleatoriamente em 15 tanques (n=5), contendo 100 L de água cada, abastecidos com água corrente desprovida de cloro, para constituir os seguintes tratamentos: TO (Controle - não tratado com doxiciclina); T1, T2, T3 e T4 (tratados com 10, 20, 40 e 80mg de doxiciclina/kg de p.v., respectivamente. 5 animais por tratamento foram amostrados em 3 períodos: 2, 4 e 8 dias pós-tratamento (DPT). Foram coletadas amostras de sangue para determinação do hemograma e avaliação do bioquímico sérico, além de órgãos como baço, fígado e rins (cranial e caudal) para avaliação somática e histopatológica. Os resultados não mostraram diferença significativa entre os tratamentos nos valores séricos de creatinina, proteína total, colesterol, triglicerídeos, globulina, glicemia e atividade da enzima fosfatase alcalina. No entanto, os níveis séricos de AST (aspartato aminotransferase) foram significativamente maiores (P<0,05) nos animais tratados com 80 mg de doxiciclina no período mais longo de tratamento (8 dias). Na avaliação hematológica de tilápias tratadas com doxiciclina, não foram observadas alterações significativas (P>0,05) nas contagens de eritrocitos, valores de hematocrito, VCM, HCM e CHCM. Tilápias tratadas com doxiciclina não apresentaram diferença significativa na análise somática do baço, fígado e rim quando comparadas aos animais do grupo controle. Portanto, os resultados demonstraram a segurança clínica do tratamento oral com doxiciclina nas doses de 10, 20, 40 e 80 mg/kg de peso corporal, embora alterações transitórias na funcionalidade hepática tenham sido observadas após oito dias de tratamento com a dose de 80mg/kg.

Assuntos

RESUMO

Lincomycin is a broad-spectrum antimicrobial acting against Gram-positive bacteria, widely used in veterinary medicine. In fish, there are only limited in vitro data, thus requiring the design of effective therapeutic protocols for their use in aquatic organisms. In this context, the objective was to evaluate the clinical safety of lincomycin treatment, administered orally in tilapia, through hematological, biochemical and somatic index evaluation. A total of 136 tilapia (+100g) were randomly distributed in 17 tanks (100L of water, n=8) to constitute the following treatments: TO (control group, not treated with lincomycin); T1, T2, T3 (treated with 10, 20 and 40mg/kg¹ of lincomycin b.w., respectively) and T4 physiological standard (reference values). Eight animals were sampled per treatment in 4 periods: 2, 4 and 8 days post-treatment (DPT), and a group that was treated for 8 days with the drug and then treated only with commercial feed until the 12th day (recovery period). Tilapia treated with lincomycin had no difference in the hematological and leukocyte evaluation, in the hepatic, renal and splenic somatic index. However, they presented a transient increase in the values of ALT, AST, cholesterol, triglycerides and creatinine, which returned to normal levels after the period of recovery (12DPT). Furthermore, an increase in total protein, albumin and globulin levels was observed in treated animals. It is concluded that although there were some transient changes during the experiment, lincomycin has a good clinical safety margin at doses of 10, 20 and 40mg/Kg¹ b.w. for Nile tilapia.

A lincomicina é um antimicrobiano de amplo espectro atuando contra bactérias gram-positivas, amplamente utilizada na medicina veterinária. Em peixes existem apenas dados limitados in-vitro, necessitando assim, de delineamento de protocolos terapêuticos eficazes para seu uso em organismos aquáticos. Desse modo, objetivou-se avaliar a segurança clínica do tratamento com lincomicina, administrada por via oral em tilápias, por meio da avaliação hematológica, bioquímica e indice somático hepático, renal e esplênico. Foram utilizadas 136 tilápias (±100g), distribuídas aleatoriamente em 17 tanques (100L de água, n=8) para constituir as repetições dos diferentes tratamentos: TO (grupo controle, não tratado com lincomicina); T1, T2, T3 (tratados com 10, 20 e 40mg/kg de p.v. de lincomicina, respectivamente) e T4 padrão fisiológico (valores de referência). Oito animais foram amostrados por tratamento em 4 períodos: 2, 4 e 8 dias pós-tratamento (DPT) com lincomicina, e um grupo que foi tratado por 8 dias com o fármaco e após isso tratado apenas com ração comercial até o 12º dia (período de recuperação). Tilápias tratadas com lincomicina não tiveram diferença na avaliação hematológica e leucocitária, no índice somático hepático, renal e esplênico, entretanto, apresentaram um aumento transitório nos valores de ALT, AST, colesterol, triglicérides e creatinina, que retornaram aos níveis normais após o período de recuperação (12DPT). Ademais, foram observados um incremento nos níveis de proteína total, albumina e globulina nos animais tratados. Conclui-se que embora tenha ocorrido algumas alterações transitórias ao decorrer do experimento, a lincomicina apresenta boa margem de segurança clinica nas doses de 10, 20 e 40mg/Kg¹ p.v para tilápia do Nilo.

Assuntos

RESUMO

This study aims to demonstrate the applicability and importance of zebrafish (Danio rerio) model to study acute and chronic inflammatory responses induced by different stimuli: carrageenan phlogogen (nonimmune); acute infection by bacteria (immune); foreign body reaction (chronic inflammation by round glass coverslip implantation); reaction induced by xenotransplantation. In addition to the advantages of presenting low breeding cost, high prolificity, transparent embryos, high number of individuals belonging to the same spawning and high genetic similarity that favor translational responses to vertebrate organisms like humans, zebrafish proved to be an excellent tool, allowing the evaluation of edema formation, accumulation of inflammatory cells in the exudate, mediators, signaling pathways, gene expression and production of specific proteins. Our studies demonstrated the versatility of fish models to investigate the inflammatory response and its pathophysiology, essential for the successful development of studies to discover innovative pharmacological strategies.

Assuntos

RESUMO

The objective of this study is to determine the infection status of nematode larvae and record epidemiological molecular data in commercial fish from the southeast Pacific off the central coast of Peru. Anisakiasis is a fish-borne zoonosis caused by Anisakis larvae, parasites of relevance in the fishery resources that have negative impact on public health. Between January 2012 to December 2014, 345 specimens of four fish species (Trachurus symmetricus murphyi, Scomber japonicus peruanus, Merluccius gayi peruanus and Seriolella violacea) were examined for Anisakis sp. larvae. A total of 997 Anisakis sp. larvae were found in the body cavity of 196 fish (total prevalence 53.7%, total mean intensity 5.08). After morphological analysis, 958 (96.08%) larvae were identified as Type I and 39 (3.92%) as Type II. Specimens were identified by molecular analysis of the mitochondrial cytochrome c oxidase subunit II (cox2) gene, confirming that A. pegreffii is the predominant species and the most important agent of human anisakiasis off the Peru Central Coast. In addition, we revealed the occurrence of A. physeteris (s.l.) in S. japonicus peruanus (P = 18.0%; MI = 2.17). Therefore, the results obtained in the present study improve the knowledge of the occurrence of Anisakis species in the commercial fish from the Southeastern Pacific Ocean, highlighting the importance of considering a potential hazard for humans and the necessity of further research in other fishes of greater preference by the Peruvian population.

RESUMO

This study aimed to evaluate the effect of astaxanthin on the hematological, biochemical and somatic response of Nile tilapia (Oreochromis niloticus) orally administered in the feed for a period of 60 days. For the study, 105 tilapia (n=35) from the same spawn were used, constituting the following treatments: Control = animals (not treated with astaxanthin); T100 and T200 = fish treated with 100 and 200 mg of astaxanthin/kg of feed, respectively. There were no hematological alterations in red blood cells counts, hematocrit, hemoglobin, MCV and MCHC. In addition, astaxanthin-fed tilapia presented a better thrombocyte and leukocyte responses with a marked decrease in the number of thrombocytes, lymphocytes and neutrophils. Among treatments, there were no changes in serum levels of total protein, albumin, globulins, aspartate aminotransferase and alkaline phosphate. Treatment with astaxanthin resulted in a decrease in triglyceride and glucose levels, as well as increase in hepatosomatic indices. The results of hematological and biochemical analyzes of tilapias demonstrated the clinical safety of this carotenoid, not causing harmful effects to the health of fish. Therefore, the antioxidant activity of this compound in tilapias resulted in an improvement in the leukocyte profile and contributed to hypolipidemic effects at the dose of 200mg of astaxanthin/kg of feed.

Objetivou-se avaliar o efeito da astaxantina na resposta hematológica, bioquímica e somática de tilápias do Nilo (Oreochromis niloticus) administrada via oral na ração por período de 60 dias. Para o estudo foram utilizadas 105 tilápias (n=35) oriundas da mesma desova, constituindo os seguintes tratamentos: Controle = animais (não tratados com astaxantina); T100= Animais tratados com 100mg de astaxantina/kg de ração; T200= Animais tratados com 200mg astaxantina/kg de ração. Não se observou alterações hematológicas na série vermelha (glóbulos vermelhos, hematócrito, hemoglobina, VCM e CHCM), além disso, apresentou melhor resposta trombocitária e leucocitária com marcada diminuição no número de linfócitos e neutrófilos. Não ocorreu alterações nos níveis séricos de proteína total, albumina, globulinas, aspartate aminotransferase e fostatase alcalina. O tratamento com astaxantina resultou em diminuição nos níveis de triglicerídeos, glicose e aumento nos índices hepatossomáticos. Portanto, os resultados das análises hematológicas e bioquímicas das tilápias demonstraram a segurança clínica desse carotenóide, não causando efeitos nocivos à saúde dos peixes. No entanto, a atividade antioxidante desse composto em tilápias resultou em melhora do perfil leucocitário e contribuiu para efeitos hipolipemiantes na dose de 200mg de astaxantina / kg de ração.

Assuntos

RESUMO

This study aimed to evaluate the effect of astaxanthin on the hematological, biochemical and somatic response of Nile tilapia (Oreochromis niloticus) orally administered in the feed for a period of 60 days. For the study, 105 tilapia (n=35) from the same spawn were used, constituting the following treatments: Control = animals (not treated with astaxanthin); T100 and T200 = fish treated with 100 and 200 mg of astaxanthin/kg of feed, respectively. There were no hematological alterations in red blood cells counts, hematocrit, hemoglobin, MCV and MCHC. In addition, astaxanthin-fed tilapia presented a better thrombocyte and leukocyte responses with a marked decrease in the number of thrombocytes, lymphocytes and neutrophils. Among treatments, there were no changes in serum levels of total protein, albumin, globulins, aspartate aminotransferase and alkaline phosphate. Treatment with astaxanthin resulted in a decrease in triglyceride and glucose levels, as well as increase in hepatosomatic indices. The results of hematological and biochemical analyzes of tilapias demonstrated the clinical safety of this carotenoid, not causing harmful effects to the health of fish. Therefore, the antioxidant activity of this compound in tilapias resulted in an improvement in the leukocyte profile and contributed to hypolipidemic effects at the dose of 200mg of astaxanthin/kg of feed.(AU)

Objetivou-se avaliar o efeito da astaxantina na resposta hematológica, bioquímica e somática de tilápias do Nilo (Oreochromis niloticus) administrada via oral na ração por período de 60 dias. Para o estudo foram utilizadas 105 tilápias (n=35) oriundas da mesma desova, constituindo os seguintes tratamentos: Controle = animais (não tratados com astaxantina); T100= Animais tratados com 100mg de astaxantina/kg de ração; T200= Animais tratados com 200mg astaxantina/kg de ração. Não se observou alterações hematológicas na série vermelha (glóbulos vermelhos, hematócrito, hemoglobina, VCM e CHCM), além disso, apresentou melhor resposta trombocitária e leucocitária com marcada diminuição no número de linfócitos e neutrófilos. Não ocorreu alterações nos níveis séricos de proteína total, albumina, globulinas, aspartate aminotransferase e fostatase alcalina. O tratamento com astaxantina resultou em diminuição nos níveis de triglicerídeos, glicose e aumento nos índices hepatossomáticos. Portanto, os resultados das análises hematológicas e bioquímicas das tilápias demonstraram a segurança clínica desse carotenóide, não causando efeitos nocivos à saúde dos peixes. No entanto, a atividade antioxidante desse composto em tilápias resultou em melhora do perfil leucocitário e contribuiu para efeitos hipolipemiantes na dose de 200mg de astaxantina / kg de ração.(AU)

Assuntos

RESUMO

This study aims to demonstrate the applicability and importance of zebrafish (Danio rerio) model to study acute and chronic inflammatory responses induced by different stimuli: carrageenan phlogogen (nonimmune); acute infection by bacteria (immune); foreign body reaction (chronic inflammation by round glass coverslip implantation); reaction induced by xenotransplantation. In addition to the advantages of presenting low breeding cost, high prolificity, transparent embryos, high number of individuals belonging to the same spawning and high genetic similarity that favor translational responses to vertebrate organisms like humans, zebrafish proved to be an excellent tool, allowing the evaluation of edema formation, accumulation of inflammatory cells in the exudate, mediators, signaling pathways, gene expression and production of specific proteins. Our studies demonstrated the versatility of fish models to investigate the inflammatory response and its pathophysiology, essential for the successful development of studies to discover innovative pharmacological strategies.

RESUMO

Resumo Os peixes teleósteos são organismos que, geralmente, apresentam limite de crescimento indeterminado e estão presentes em diferentes biomas com diversas características ambientais. Os teleósteos possuem até 80% de sua composição corporal formado por tecido muscular, composto por fibras musculares e células satélites indiferenciadas, formando um tecido muscular complexo cuja forma é muito variada em função das espécies que compõem este grupo de animais. Um ponto importante a ser considerado é que o crescimento muscular dos peixes é influenciado pelas condições ambientais em que estão inseridos. Esta influência ocorre à nível molecular afetando a transcrição e funcionalidade de diferentes transcritos relacionados à miogênese em diferentes fases do desenvolvimento dos peixes. Esta revisão tem o objetivo de discutir alguns dos pontos chave sobre a influência dos fatores ambientais sobre o desenvolvimento e crescimento muscular dos peixes.

Abstract Teleost fish are organisms that generally show an indeterminate growth limit and are present in different biomes with different environmental conditions. Approximately up to 80% of the body composition of fish is formed by muscle tissue. Muscle tissue is composed of muscle fibers and undifferentiated satellite cells, forming a complex tissue that shows a widely varied shape depending on the species which form this group of animals. An important point to be considered is that the muscle growth of the fish is influenced by the environmental conditions in which they are inserted. This influence occurs at the molecular level, affecting the transcription and functionality of different transcripts related to myogenesis at different stages of fish development. This review aims to discuss some of the key aspects about the influence of environmental factors on the development and muscle growth of teleost fish.

Resumen Los peces teleósteos son organismos que generalmente tienen un límite de crecimiento indeterminado y están presentes en diferentes biomas con diferentes características ambientales. Los teleósteos poseen hasta el 80% de su composición corporal compuesta de tejido muscular, compuesto por fibras musculares y células satélite indiferenciadas, formando un tejido muscular complejo cuya forma es muy variada dependiendo de las especies que componen este grupo de animales. Un punto importante por considerar es que el crecimiento muscular de los peces está influenciado por las condiciones ambientales en que están inseridos. Esta influencia ocurre a nivel molecular, afectando la transcripción y la funcionalidad de diferentes transcripciones relacionadas con la miogénesis en diferentes etapas del desarrollo de los peces. Esta revisión tiene como objetivo discutir algunos de los puntos clave sobre la influencia de los factores ambientales en el desarrollo y el crecimiento muscular de los peces.

RESUMO

Streptococcus agalactiae (Sta) of Lancefield group B is the primary etiological agent of bacterial meningitis in Nile tilapia and newborn humans. Thus, the study of this disease is of fundamental importance for aquaculture and human medicine. Additionally, elucidation of the mechanisms involved in the host-pathogenic response is important for the success of new therapies. In the present study, we elucidated important aspects of the innate immune response in the brain tissue of Nile tilapia (Oreochromis niloticus) infected by Sta. The neuroinflammatory process in the meninges started with the migration of MHC class II and CD68 + cells, production of TNF-alpha, and the effective immune response to Sta was mediated by the increased iNOs+. In conclusion, the present study brings a partial understanding of the pathophysiological and neuroinflammatory mechanisms in meningitis in Sta infected tilapia, enabling important advances in the therapy of this disease as well as the possibility of using this biological model to understand human meningitis.